Yingfeng Lin

1.0k citations
28 papers · 766 · 1 hit paper · h-index 12

Impact in

Papers in

Yingfeng Lin

28 papers receiving 751 citations

Yingfeng Lin's Hit Papers

Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia 2015 · 307 citations
3070+3+7Years since publication100200300

Peers

Yingfeng Lin
Comparison fields: 5 of 89
  • Cardiology and Cardiovascular Medicine 159
  • Surgery 312
  • Cancer Research 69
  • Internal Medicine 15
  • Geriatrics and Gerontology 15
Replace Songbai Deng with:
Songbai Deng China
Lina Kang China
А. И. Ершова Russia
Michalina Kołodziejczak Poland
Melchior C. Nierman Netherlands
Michael Tsang Canada
Julia Maria Kubica Poland
Volker Schulze Germany
Xue-Qiao Zhao United States
Yingfeng Lin relative to Songbai Deng China Songbai Deng's profile →
Citations per field
00.5×3.8×
Songbai Deng · 1×
Citations per year

Countries citing papers authored by Yingfeng Lin

Since Specialization
Citations

This map shows the geographic impact of Yingfeng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingfeng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingfeng Lin more than expected).

Fields of papers citing papers by Yingfeng Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingfeng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingfeng Lin. The network helps show where Yingfeng Lin may publish in the future.

Co-authors

The 25 scholars most cited alongside Yingfeng Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yingfeng Lin Line = papers co-authored together Yingfeng Lin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia
Hit paper breakdown →
2015307
2 201067
3 201945
4 201943
5 201943
6 202041
7 201732
8 202030
9 202225
10 201918
11 201317
12 201812
13 201811
14 201910
15 20159
16 20228
17 20237
18 20227
19 20226
20 20216

About Yingfeng Lin

Yingfeng Lin is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Molecular Biology, Physiology and Immunology, having authored 28 papers that have together received 766 indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (3 papers), Atrial Fibrillation Management and Outcomes (3 papers), Asthma and respiratory diseases (2 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers), Venous Thromboembolism Diagnosis and Management (1 paper), Cardiac, Anesthesia and Surgical Outcomes (1 paper), Plant nutrient uptake and metabolism (1 paper) and Aluminum toxicity and tolerance in plants and animals (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (159 citations), Surgery (312 citations), Cancer Research (69 citations), Internal Medicine (15 citations) and Geriatrics and Gerontology (15 citations). Yingfeng Lin has collaborated with scholars based in Germany, China and United States. Frequent co-authors include Malte Kelm, Maximilian Brockmeyer, Volker Schulze, Georg Wolff, Michalina Kołodziejczak, Eliano Pio Navarese, Jacek Kubica, Udaya S. Tantry, Paul A. Gurbel and David E. Kandzari. Their work appears in journals such as Clinical Research in Cardiology, International Journal of Cardiology, Journal of Pharmacology and Experimental Therapeutics, Frontiers in Plant Science and BMC Cardiovascular Disorders.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact